120 related articles for article (PubMed ID: 21083978)
1. [Ambroxol for the prevention of respiratory distress syndrome in preterm infants: a meta analysis].
Zhang ZQ; Huang XM; Lu H
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Nov; 12(11):858-63. PubMed ID: 21083978
[TBL] [Abstract][Full Text] [Related]
2. Prevention of respiratory distress syndrome in preterm infants by antenatal ambroxol: a meta-analysis of randomized controlled trials.
Zhang ZQ; Wu QQ; Huang XM; Lu H
Am J Perinatol; 2013 Aug; 30(7):529-36. PubMed ID: 23229957
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of intravenous or atomizing ambroxol for prevention of respiratory distress syndrome in preterm infants].
Hu Q; Lian JM; Li JQ
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):301-3. PubMed ID: 16923362
[TBL] [Abstract][Full Text] [Related]
4. [Antenatal ambroxol administration for prevention of respiratopry distress syndrome in preterm infants: preliminary report].
Marinov B; Jekova N; Andreeva A; Hitrova S
Akush Ginekol (Sofiia); 2011; 50(4):17-22. PubMed ID: 22479892
[TBL] [Abstract][Full Text] [Related]
5. A study of cellular immunity in newborns after prevention of respiratory distress syndrome (RDS).
Lazzarin A; Luerti M; Capsoni F; Galli M; Uberti-Foppa C; Zavattini G; Corbella E
Int J Tissue React; 1986; 8(2):157-65. PubMed ID: 3700005
[TBL] [Abstract][Full Text] [Related]
6. Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD).
Schmalisch G; Wauer RR; Böhme B
Respir Med; 2000 Apr; 94(4):378-84. PubMed ID: 10845438
[TBL] [Abstract][Full Text] [Related]
7. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks' gestation.
Smith LM; Qureshi N; Chao CR
J Matern Fetal Med; 2000; 9(2):131-5. PubMed ID: 10902829
[TBL] [Abstract][Full Text] [Related]
8. Antenatal maternal medication administration in preventing respiratory distress syndrome of premature infants: A network meta-analysis.
Zhang H; Liu J; Liu T; Wang Y; Dai W
Clin Respir J; 2018 Oct; 12(10):2480-2490. PubMed ID: 30074296
[TBL] [Abstract][Full Text] [Related]
9. Polymorphonuclear leucocytes functions from premature infants after prevention of respiratory distress syndrome with betamethasone and ambroxol.
Lazzarin A; Luerti M; Uberti-Foppa C; Zavattini G; Rossi A; Tornaghi R
Biol Res Pregnancy Perinatol; 1984; 5(3):130-4. PubMed ID: 6478010
[TBL] [Abstract][Full Text] [Related]
10. Effect of prenatal T4 treatment in neonatal morbidity: preliminary findings.
Reyes G; Romaguera J; Zapata R; Valcarcel M; Adamsons K
P R Health Sci J; 1997 Mar; 16(1):5-8. PubMed ID: 9160396
[TBL] [Abstract][Full Text] [Related]
11. The effect of surfactant replacement therapy on conditions associated with respiratory distress syndrome: patent ductus arteriosus, intraventricular hemorrhage, and bronchopulmonary dysplasia.
Kendig JW; Sinkin RA
Semin Perinatol; 1988 Jul; 12(3):255-8. PubMed ID: 3041608
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of pulmonary application of corticosteroids in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.
Delara M; Chauhan BF; Le ML; Abou-Setta AM; Zarychanski R; 'tJong GW
Arch Dis Child Fetal Neonatal Ed; 2019 Mar; 104(2):F137-F144. PubMed ID: 29666203
[TBL] [Abstract][Full Text] [Related]
13. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
14. Cord blood prolactin and thyroid hormone levels after antenatal administration of betamethasone or ambroxol for prevention of respiratory distress syndrome (RDS).
Luerti M; Spagnolo D; Zavattini G; Bianchi C; Barbera AG; Corbella E
Biol Res Pregnancy Perinatol; 1984; 5(3):124-9. PubMed ID: 6548163
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of different dosages of ambroxol hydrochloride in the prevention of neonatal respiratory distress syndrome].
Fan YZ; Wen ZL
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Sep; 11(9):771-2. PubMed ID: 19755033
[No Abstract] [Full Text] [Related]
16. [RDS prevention by prednilyden and ambroxol. A comparative study].
Geibel W; Rindt W; Becker H
Arch Gynecol; 1979 Jul; 228(1-4):204. PubMed ID: 582652
[No Abstract] [Full Text] [Related]
17. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
[TBL] [Abstract][Full Text] [Related]
18. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
Robertson B
Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
[TBL] [Abstract][Full Text] [Related]
19. An alternative to steroids for prevention of respiratory distress syndrome (RDS): multicenter controlled study to compare ambroxol and betamethasone.
Luerti M; Lazzarin A; Corbella E; Zavattini G
J Perinat Med; 1987; 15(3):227-38. PubMed ID: 3323457
[TBL] [Abstract][Full Text] [Related]
20. [Respiratory distress syndrome in premature births].
Grio R; Marchino GL; Giobbe C; Zaccheo F; Ferrara L; Castello C; Ardissone D; Mazza O; Piacentino R
Minerva Ginecol; 1990 Nov; 42(11):443-5. PubMed ID: 2080031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
